13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmore
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
28.02.2024 – 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigOne documentmore
22.02.2024 – 13:23Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmore
18.01.2024 – 10:00PNO Innovation GmbH2OPTIMA cancer project announces the Region Uppsala as new partnerCheck out the OPTIMA Videomore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupOne documentmore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmore
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmore
25.10.2022 – 09:00Metrics in BalanceMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalksmore
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmore
22.03.2022 – 14:00Lemon from SpainThree benefits that make lemon a key food in the Mediterranean dietmore
19.01.2022 – 12:51News DirectALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERSmore
17.12.2021 – 11:35EvoCare Holding AGDigital health platform helps to expand conventional medical services / EvoCare invites investors to support global roll-outmore
08.11.2021 – 14:17SYNformulas GmbHCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalizationmore
20.10.2021 – 16:30Sysmex Inostics GmbHNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inosticsmore
04.10.2021 – 11:25News Direct2#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Membermore
01.07.2021 – 16:04News Direct3Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Accessmore
27.05.2021 – 10:35BrainRepair UGInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15Mmore
13.04.2021 – 14:04Fördergesellschaft IZB mbH2Lindis Biotech develops immunotherapy against bladder cancerIn the IZB you can find over 50 biotech start-upsOne documentmore
02.03.2021 – 14:36B. Braun Melsungen AG2B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®more
03.02.2021 – 13:30Fördergesellschaft IZB mbH3World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic toolsIn the IZB you can find over 50 biotech start-upsOne documentmore
30.09.2020 – 13:00BrainRepair UGRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Planmore
16.06.2020 – 12:51DERMALOG Identification Systems GmbHDERMALOG Contactless Fever Checks at Medical Practicesmore
04.06.2020 – 14:16SYNformulas GmbH2Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipationmore